Robert Blum | Investor Relations-Lytham Partners |
Steve Shum | Chief Executive Officer |
Mike Campbell | Chief Operating Officer and Vice President of Business Development |
Kyle Bauser | Colliers Securities |
John Heerdink | Vista Partners |
Good day and welcome to the INVO Bioscience reports Fourth Quarter and Fiscal Year 2020 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I'd now like to turn the conference over to Robert Blum with Lytham Partners.